系统性狼与红斑血相关的肺部疾病
Elisabeth Bendstrup1,2, Evelyn Lynn3,4, Anne Troldborg2,5,6
1Center for Rare Lung Disease, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Seminars in respiratory and critical care medicine
|March 28, 2024
概括
肺部干扰显著影响全身性红斑狼 (SLE) 患者,导致严重疾病和死亡. 本综述详细介绍了SLE肺部疾病,强调需要更好的诊断和治疗指南.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病,影响多个器官系统.
- 肺部表现是SLE患者患病和死亡的主要原因.
- 在SLE中,可以发生广泛的肺部疾病,从呼吸道到辅酶体和血管疾病.
研究的目的:
- 提供与SLE相关的肺部疾病的全面概述.
- 讨论这些表现的诊断方法和治疗策略.
- 突出需要基于证据的指导方针来改善患者的治疗结果.
主要方法:
- 这是关于SLE肺部参与的文献的综合性综述.
- 该综述将肺部表现分为上呼吸道,下呼吸道,体,体和血管疾病.
- 对每个类别的诊断方式,治疗选择和预后进行了讨论.
主要成果:
- 肺部参与SLE包括广泛的条件,包括间歇性肺病,扩散性气膜出血,肺动脉高血压和缩小肺综合征.
- 诊断方面的挑战仍然存在,目前还缺乏标准化的治疗指南.
- 有效的管理需要对各种肺部症状及其具体治疗方法有充分的了解.
结论:
- 肺部疾病是SLE的一个关键和经常被忽视的方面.
- 改进的诊断工具和基于证据的治疗指南对于优化SLE患者的治疗和预后至关重要.
- 需要进一步的研究来建立标准化的管理协议.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Other Pulmonary Disorders
837
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
837
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Acute Respiratory Failure-II
222
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
222


